Gastroesophageal Reflux Disease (GERD) is a digestive disorder that occurs when acidic stomach juices, or food and fluids back up from the stomach into the esophagus.GERD affects people of all ages—from infants to older adults. People with asthma are at higher risk of developing GERD.

The global Gastroesophageal Reflux Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Gastroesophageal Reflux Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastroesophageal Reflux Drugs.

Report Scope

The Gastroesophageal Reflux Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gastroesophageal Reflux Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gastroesophageal Reflux Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Gastroesophageal Reflux Drugs Market Report

Report Metric	Details
Report Name	Gastroesophageal Reflux Drugs Market
CAGR	5%
Segment by Type	Esomeprazole Lansoprazole Omeprazole Rbeprazole Dexlansoprazole Others
Segment by Application	Hospitals Ambulatory surgical centers Specialty clinics Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Bayer, Cadila Pharmaceuticals, AstraZeneca, Jiangsu Aosaikang, Eisai, Pfizer, Altana Pharma, Takeda, NCPC, Luoxin
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gastroesophageal Reflux Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gastroesophageal Reflux Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Gastroesophageal Reflux Drugs Market report?

Ans: The main players in the Gastroesophageal Reflux Drugs Market are Bayer, Cadila Pharmaceuticals, AstraZeneca, Jiangsu Aosaikang, Eisai, Pfizer, Altana Pharma, Takeda, NCPC, Luoxin

What are the Application segmentation covered in the Gastroesophageal Reflux Drugs Market report?

Ans: The Applications covered in the Gastroesophageal Reflux Drugs Market report are Hospitals, Ambulatory surgical centers, Specialty clinics, Others

What are the Type segmentation covered in the Gastroesophageal Reflux Drugs Market report?

Ans: The Types covered in the Gastroesophageal Reflux Drugs Market report are Esomeprazole, Lansoprazole, Omeprazole, Rbeprazole, Dexlansoprazole, Others

1 Gastroesophageal Reflux Drugs Market Overview

1.1 Product Overview and Scope of Gastroesophageal Reflux Drugs

1.2 Gastroesophageal Reflux Drugs Segment by Type

1.2.1 Global Gastroesophageal Reflux Drugs Market Value Comparison by Type (2024-2030)

1.2.2 Esomeprazole

1.2.3 Lansoprazole

1.2.4 Omeprazole

1.2.5 Rbeprazole

1.2.6 Dexlansoprazole

1.2.7 Others

1.3 Gastroesophageal Reflux Drugs Segment by Application

1.3.1 Global Gastroesophageal Reflux Drugs Market Value by Application: (2024-2030)

1.3.2 Hospitals

1.3.3 Ambulatory surgical centers

1.3.4 Specialty clinics

1.3.5 Others

1.4 Global Gastroesophageal Reflux Drugs Market Size Estimates and Forecasts

1.4.1 Global Gastroesophageal Reflux Drugs Revenue 2019-2030

1.4.2 Global Gastroesophageal Reflux Drugs Sales 2019-2030

1.4.3 Global Gastroesophageal Reflux Drugs Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Gastroesophageal Reflux Drugs Market Competition by Manufacturers

2.1 Global Gastroesophageal Reflux Drugs Sales Market Share by Manufacturers (2019-2024)

2.2 Global Gastroesophageal Reflux Drugs Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Gastroesophageal Reflux Drugs Average Price by Manufacturers (2019-2024)

2.4 Global Gastroesophageal Reflux Drugs Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Gastroesophageal Reflux Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Gastroesophageal Reflux Drugs, Product Type & Application

2.7 Gastroesophageal Reflux Drugs Market Competitive Situation and Trends

2.7.1 Gastroesophageal Reflux Drugs Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Gastroesophageal Reflux Drugs Players Market Share by Revenue

2.7.3 Global Gastroesophageal Reflux Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Gastroesophageal Reflux Drugs Retrospective Market Scenario by Region

3.1 Global Gastroesophageal Reflux Drugs Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Gastroesophageal Reflux Drugs Global Gastroesophageal Reflux Drugs Sales by Region: 2019-2030

3.2.1 Global Gastroesophageal Reflux Drugs Sales by Region: 2019-2024

3.2.2 Global Gastroesophageal Reflux Drugs Sales by Region: 2025-2030

3.3 Global Gastroesophageal Reflux Drugs Global Gastroesophageal Reflux Drugs Revenue by Region: 2019-2030

3.3.1 Global Gastroesophageal Reflux Drugs Revenue by Region: 2019-2024

3.3.2 Global Gastroesophageal Reflux Drugs Revenue by Region: 2025-2030

3.4 North America Gastroesophageal Reflux Drugs Market Facts & Figures by Country

3.4.1 North America Gastroesophageal Reflux Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Gastroesophageal Reflux Drugs Sales by Country (2019-2030)

3.4.3 North America Gastroesophageal Reflux Drugs Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Gastroesophageal Reflux Drugs Market Facts & Figures by Country

3.5.1 Europe Gastroesophageal Reflux Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Gastroesophageal Reflux Drugs Sales by Country (2019-2030)

3.5.3 Europe Gastroesophageal Reflux Drugs Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Gastroesophageal Reflux Drugs Market Facts & Figures by Country

3.6.1 Asia Pacific Gastroesophageal Reflux Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Gastroesophageal Reflux Drugs Sales by Country (2019-2030)

3.6.3 Asia Pacific Gastroesophageal Reflux Drugs Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Gastroesophageal Reflux Drugs Market Facts & Figures by Country

3.7.1 Latin America Gastroesophageal Reflux Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Gastroesophageal Reflux Drugs Sales by Country (2019-2030)

3.7.3 Latin America Gastroesophageal Reflux Drugs Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Gastroesophageal Reflux Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Gastroesophageal Reflux Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Gastroesophageal Reflux Drugs Sales by Country (2019-2030)

3.8.3 Middle East and Africa Gastroesophageal Reflux Drugs Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Gastroesophageal Reflux Drugs Sales by Type (2019-2030)

4.1.1 Global Gastroesophageal Reflux Drugs Sales by Type (2019-2024)

4.1.2 Global Gastroesophageal Reflux Drugs Sales by Type (2025-2030)

4.1.3 Global Gastroesophageal Reflux Drugs Sales Market Share by Type (2019-2030)

4.2 Global Gastroesophageal Reflux Drugs Revenue by Type (2019-2030)

4.2.1 Global Gastroesophageal Reflux Drugs Revenue by Type (2019-2024)

4.2.2 Global Gastroesophageal Reflux Drugs Revenue by Type (2025-2030)

4.2.3 Global Gastroesophageal Reflux Drugs Revenue Market Share by Type (2019-2030)

4.3 Global Gastroesophageal Reflux Drugs Price by Type (2019-2030)

5 Segment by Application

5.1 Global Gastroesophageal Reflux Drugs Sales by Application (2019-2030)

5.1.1 Global Gastroesophageal Reflux Drugs Sales by Application (2019-2024)

5.1.2 Global Gastroesophageal Reflux Drugs Sales by Application (2025-2030)

5.1.3 Global Gastroesophageal Reflux Drugs Sales Market Share by Application (2019-2030)

5.2 Global Gastroesophageal Reflux Drugs Revenue by Application (2019-2030)

5.2.1 Global Gastroesophageal Reflux Drugs Revenue by Application (2019-2024)

5.2.2 Global Gastroesophageal Reflux Drugs Revenue by Application (2025-2030)

5.2.3 Global Gastroesophageal Reflux Drugs Revenue Market Share by Application (2019-2030)

5.3 Global Gastroesophageal Reflux Drugs Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Bayer

6.1.1 Bayer Corporation Information

6.1.2 Bayer Description and Business Overview

6.1.3 Bayer Gastroesophageal Reflux Drugs Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Bayer Gastroesophageal Reflux Drugs Product Portfolio

6.1.5 Bayer Recent Developments/Updates

6.2 Cadila Pharmaceuticals

6.2.1 Cadila Pharmaceuticals Corporation Information

6.2.2 Cadila Pharmaceuticals Description and Business Overview

6.2.3 Cadila Pharmaceuticals Gastroesophageal Reflux Drugs Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Cadila Pharmaceuticals Gastroesophageal Reflux Drugs Product Portfolio

6.2.5 Cadila Pharmaceuticals Recent Developments/Updates

6.3 AstraZeneca

6.3.1 AstraZeneca Corporation Information

6.3.2 AstraZeneca Description and Business Overview

6.3.3 AstraZeneca Gastroesophageal Reflux Drugs Sales, Revenue and Gross Margin (2019-2024)

6.3.4 AstraZeneca Gastroesophageal Reflux Drugs Product Portfolio

6.3.5 AstraZeneca Recent Developments/Updates

6.4 Jiangsu Aosaikang

6.4.1 Jiangsu Aosaikang Corporation Information

6.4.2 Jiangsu Aosaikang Description and Business Overview

6.4.3 Jiangsu Aosaikang Gastroesophageal Reflux Drugs Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Jiangsu Aosaikang Gastroesophageal Reflux Drugs Product Portfolio

6.4.5 Jiangsu Aosaikang Recent Developments/Updates

6.5 Eisai

6.5.1 Eisai Corporation Information

6.5.2 Eisai Description and Business Overview

6.5.3 Eisai Gastroesophageal Reflux Drugs Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Eisai Gastroesophageal Reflux Drugs Product Portfolio

6.5.5 Eisai Recent Developments/Updates

6.6 Pfizer

6.6.1 Pfizer Corporation Information

6.6.2 Pfizer Description and Business Overview

6.6.3 Pfizer Gastroesophageal Reflux Drugs Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Pfizer Gastroesophageal Reflux Drugs Product Portfolio

6.6.5 Pfizer Recent Developments/Updates

6.7 Altana Pharma

6.6.1 Altana Pharma Corporation Information

6.6.2 Altana Pharma Description and Business Overview

6.6.3 Altana Pharma Gastroesophageal Reflux Drugs Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Altana Pharma Gastroesophageal Reflux Drugs Product Portfolio

6.7.5 Altana Pharma Recent Developments/Updates

6.8 Takeda

6.8.1 Takeda Corporation Information

6.8.2 Takeda Description and Business Overview

6.8.3 Takeda Gastroesophageal Reflux Drugs Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Takeda Gastroesophageal Reflux Drugs Product Portfolio

6.8.5 Takeda Recent Developments/Updates

6.9 NCPC

6.9.1 NCPC Corporation Information

6.9.2 NCPC Description and Business Overview

6.9.3 NCPC Gastroesophageal Reflux Drugs Sales, Revenue and Gross Margin (2019-2024)

6.9.4 NCPC Gastroesophageal Reflux Drugs Product Portfolio

6.9.5 NCPC Recent Developments/Updates

6.10 Luoxin

6.10.1 Luoxin Corporation Information

6.10.2 Luoxin Description and Business Overview

6.10.3 Luoxin Gastroesophageal Reflux Drugs Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Luoxin Gastroesophageal Reflux Drugs Product Portfolio

6.10.5 Luoxin Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Gastroesophageal Reflux Drugs Industry Chain Analysis

7.2 Gastroesophageal Reflux Drugs Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Gastroesophageal Reflux Drugs Production Mode & Process

7.4 Gastroesophageal Reflux Drugs Sales and Marketing

7.4.1 Gastroesophageal Reflux Drugs Sales Channels

7.4.2 Gastroesophageal Reflux Drugs Distributors

7.5 Gastroesophageal Reflux Drugs Customers

8 Gastroesophageal Reflux Drugs Market Dynamics

8.1 Gastroesophageal Reflux Drugs Industry Trends

8.2 Gastroesophageal Reflux Drugs Market Drivers

8.3 Gastroesophageal Reflux Drugs Market Challenges

8.4 Gastroesophageal Reflux Drugs Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Bayer

Cadila Pharmaceuticals

List of Tables

Table 1. Global Gastroesophageal Reflux Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Gastroesophageal Reflux Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Gastroesophageal Reflux Drugs Market Competitive Situation by Manufacturers in 2023

Table 4. Global Gastroesophageal Reflux Drugs Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Gastroesophageal Reflux Drugs Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Gastroesophageal Reflux Drugs Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Gastroesophageal Reflux Drugs Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Gastroesophageal Reflux Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Gastroesophageal Reflux Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Gastroesophageal Reflux Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Gastroesophageal Reflux Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Gastroesophageal Reflux Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Gastroesophageal Reflux Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastroesophageal Reflux Drugs as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Gastroesophageal Reflux Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Gastroesophageal Reflux Drugs Sales by Region (2019-2024) & (K Units)

Table 18. Global Gastroesophageal Reflux Drugs Sales Market Share by Region (2019-2024)

Table 19. Global Gastroesophageal Reflux Drugs Sales by Region (2025-2030) & (K Units)

Table 20. Global Gastroesophageal Reflux Drugs Sales Market Share by Region (2025-2030)

Table 21. Global Gastroesophageal Reflux Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Gastroesophageal Reflux Drugs Revenue Market Share by Region (2019-2024)

Table 23. Global Gastroesophageal Reflux Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Gastroesophageal Reflux Drugs Revenue Market Share by Region (2025-2030)

Table 25. North America Gastroesophageal Reflux Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Gastroesophageal Reflux Drugs Sales by Country (2019-2024) & (K Units)

Table 27. North America Gastroesophageal Reflux Drugs Sales by Country (2025-2030) & (K Units)

Table 28. North America Gastroesophageal Reflux Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Gastroesophageal Reflux Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Gastroesophageal Reflux Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Gastroesophageal Reflux Drugs Sales by Country (2019-2024) & (K Units)

Table 32. Europe Gastroesophageal Reflux Drugs Sales by Country (2025-2030) & (K Units)

Table 33. Europe Gastroesophageal Reflux Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Gastroesophageal Reflux Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Gastroesophageal Reflux Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Gastroesophageal Reflux Drugs Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Gastroesophageal Reflux Drugs Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Gastroesophageal Reflux Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Gastroesophageal Reflux Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Gastroesophageal Reflux Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Gastroesophageal Reflux Drugs Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Gastroesophageal Reflux Drugs Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Gastroesophageal Reflux Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Gastroesophageal Reflux Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Gastroesophageal Reflux Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Gastroesophageal Reflux Drugs Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Gastroesophageal Reflux Drugs Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Gastroesophageal Reflux Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Gastroesophageal Reflux Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Gastroesophageal Reflux Drugs Sales (K Units) by Type (2019-2024)

Table 51. Global Gastroesophageal Reflux Drugs Sales (K Units) by Type (2025-2030)

Table 52. Global Gastroesophageal Reflux Drugs Sales Market Share by Type (2019-2024)

Table 53. Global Gastroesophageal Reflux Drugs Sales Market Share by Type (2025-2030)

Table 54. Global Gastroesophageal Reflux Drugs Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Gastroesophageal Reflux Drugs Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Gastroesophageal Reflux Drugs Revenue Market Share by Type (2019-2024)

Table 57. Global Gastroesophageal Reflux Drugs Revenue Market Share by Type (2025-2030)

Table 58. Global Gastroesophageal Reflux Drugs Price (US$/Unit) by Type (2019-2024)

Table 59. Global Gastroesophageal Reflux Drugs Price (US$/Unit) by Type (2025-2030)

Table 60. Global Gastroesophageal Reflux Drugs Sales (K Units) by Application (2019-2024)

Table 61. Global Gastroesophageal Reflux Drugs Sales (K Units) by Application (2025-2030)

Table 62. Global Gastroesophageal Reflux Drugs Sales Market Share by Application (2019-2024)

Table 63. Global Gastroesophageal Reflux Drugs Sales Market Share by Application (2025-2030)

Table 64. Global Gastroesophageal Reflux Drugs Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Gastroesophageal Reflux Drugs Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Gastroesophageal Reflux Drugs Revenue Market Share by Application (2019-2024)

Table 67. Global Gastroesophageal Reflux Drugs Revenue Market Share by Application (2025-2030)

Table 68. Global Gastroesophageal Reflux Drugs Price (US$/Unit) by Application (2019-2024)

Table 69. Global Gastroesophageal Reflux Drugs Price (US$/Unit) by Application (2025-2030)

Table 70. Bayer Corporation Information

Table 71. Bayer Description and Business Overview

Table 72. Bayer Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Bayer Gastroesophageal Reflux Drugs Product

Table 74. Bayer Recent Developments/Updates

Table 75. Cadila Pharmaceuticals Corporation Information

Table 76. Cadila Pharmaceuticals Description and Business Overview

Table 77. Cadila Pharmaceuticals Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Cadila Pharmaceuticals Gastroesophageal Reflux Drugs Product

Table 79. Cadila Pharmaceuticals Recent Developments/Updates

Table 80. AstraZeneca Corporation Information

Table 81. AstraZeneca Description and Business Overview

Table 82. AstraZeneca Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. AstraZeneca Gastroesophageal Reflux Drugs Product

Table 84. AstraZeneca Recent Developments/Updates

Table 85. Jiangsu Aosaikang Corporation Information

Table 86. Jiangsu Aosaikang Description and Business Overview

Table 87. Jiangsu Aosaikang Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Jiangsu Aosaikang Gastroesophageal Reflux Drugs Product

Table 89. Jiangsu Aosaikang Recent Developments/Updates

Table 90. Eisai Corporation Information

Table 91. Eisai Description and Business Overview

Table 92. Eisai Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Eisai Gastroesophageal Reflux Drugs Product

Table 94. Eisai Recent Developments/Updates

Table 95. Pfizer Corporation Information

Table 96. Pfizer Description and Business Overview

Table 97. Pfizer Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Pfizer Gastroesophageal Reflux Drugs Product

Table 99. Pfizer Recent Developments/Updates

Table 100. Altana Pharma Corporation Information

Table 101. Altana Pharma Description and Business Overview

Table 102. Altana Pharma Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Altana Pharma Gastroesophageal Reflux Drugs Product

Table 104. Altana Pharma Recent Developments/Updates

Table 105. Takeda Corporation Information

Table 106. Takeda Description and Business Overview

Table 107. Takeda Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Takeda Gastroesophageal Reflux Drugs Product

Table 109. Takeda Recent Developments/Updates

Table 110. NCPC Corporation Information

Table 111. NCPC Description and Business Overview

Table 112. NCPC Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. NCPC Gastroesophageal Reflux Drugs Product

Table 114. NCPC Recent Developments/Updates

Table 115. Luoxin Corporation Information

Table 116. Luoxin Description and Business Overview

Table 117. Luoxin Gastroesophageal Reflux Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Luoxin Gastroesophageal Reflux Drugs Product

Table 119. Luoxin Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Gastroesophageal Reflux Drugs Distributors List

Table 123. Gastroesophageal Reflux Drugs Customers List

Table 124. Gastroesophageal Reflux Drugs Market Trends

Table 125. Gastroesophageal Reflux Drugs Market Drivers

Table 126. Gastroesophageal Reflux Drugs Market Challenges

Table 127. Gastroesophageal Reflux Drugs Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Gastroesophageal Reflux Drugs

Figure 2. Global Gastroesophageal Reflux Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Gastroesophageal Reflux Drugs Market Share by Type in 2023 & 2030

Figure 4. Esomeprazole Product Picture

Figure 5. Lansoprazole Product Picture

Figure 6. Omeprazole Product Picture

Figure 7. Rbeprazole Product Picture

Figure 8. Dexlansoprazole Product Picture

Figure 9. Others Product Picture

Figure 10. Global Gastroesophageal Reflux Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 11. Global Gastroesophageal Reflux Drugs Market Share by Application in 2023 & 2030

Figure 12. Hospitals

Figure 13. Ambulatory surgical centers

Figure 14. Specialty clinics

Figure 15. Others

Figure 16. Global Gastroesophageal Reflux Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Gastroesophageal Reflux Drugs Market Size (2019-2030) & (US$ Million)

Figure 18. Global Gastroesophageal Reflux Drugs Sales (2019-2030) & (K Units)

Figure 19. Global Gastroesophageal Reflux Drugs Average Price (US$/Unit) & (2019-2030)

Figure 20. Gastroesophageal Reflux Drugs Report Years Considered

Figure 21. Gastroesophageal Reflux Drugs Sales Share by Manufacturers in 2023

Figure 22. Global Gastroesophageal Reflux Drugs Revenue Share by Manufacturers in 2023

Figure 23. The Global 5 and 10 Largest Gastroesophageal Reflux Drugs Players: Market Share by Revenue in 2023

Figure 24. Gastroesophageal Reflux Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 25. Global Gastroesophageal Reflux Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 26. North America Gastroesophageal Reflux Drugs Sales Market Share by Country (2019-2030)

Figure 27. North America Gastroesophageal Reflux Drugs Revenue Market Share by Country (2019-2030)

Figure 28. U.S. Gastroesophageal Reflux Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Canada Gastroesophageal Reflux Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Europe Gastroesophageal Reflux Drugs Sales Market Share by Country (2019-2030)

Figure 31. Europe Gastroesophageal Reflux Drugs Revenue Market Share by Country (2019-2030)

Figure 32. Germany Gastroesophageal Reflux Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. France Gastroesophageal Reflux Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. U.K. Gastroesophageal Reflux Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Italy Gastroesophageal Reflux Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Russia Gastroesophageal Reflux Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Asia Pacific Gastroesophageal Reflux Drugs Sales Market Share by Region (2019-2030)

Figure 38. Asia Pacific Gastroesophageal Reflux Drugs Revenue Market Share by Region (2019-2030)

Figure 39. China Gastroesophageal Reflux Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Japan Gastroesophageal Reflux Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. South Korea Gastroesophageal Reflux Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. India Gastroesophageal Reflux Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Australia Gastroesophageal Reflux Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Taiwan Gastroesophageal Reflux Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Indonesia Gastroesophageal Reflux Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Thailand Gastroesophageal Reflux Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Malaysia Gastroesophageal Reflux Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Philippines Gastroesophageal Reflux Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Latin America Gastroesophageal Reflux Drugs Sales Market Share by Country (2019-2030)

Figure 50. Latin America Gastroesophageal Reflux Drugs Revenue Market Share by Country (2019-2030)

Figure 51. Mexico Gastroesophageal Reflux Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Brazil Gastroesophageal Reflux Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Argentina Gastroesophageal Reflux Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Middle East & Africa Gastroesophageal Reflux Drugs Sales Market Share by Country (2019-2030)

Figure 55. Middle East & Africa Gastroesophageal Reflux Drugs Revenue Market Share by Country (2019-2030)

Figure 56. Turkey Gastroesophageal Reflux Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 57. Saudi Arabia Gastroesophageal Reflux Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 58. UAE Gastroesophageal Reflux Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 59. Global Sales Market Share of Gastroesophageal Reflux Drugs by Type (2019-2030)

Figure 60. Global Revenue Market Share of Gastroesophageal Reflux Drugs by Type (2019-2030)

Figure 61. Global Gastroesophageal Reflux Drugs Price (US$/Unit) by Type (2019-2030)

Figure 62. Global Sales Market Share of Gastroesophageal Reflux Drugs by Application (2019-2030)

Figure 63. Global Revenue Market Share of Gastroesophageal Reflux Drugs by Application (2019-2030)

Figure 64. Global Gastroesophageal Reflux Drugs Price (US$/Unit) by Application (2019-2030)

Figure 65. Gastroesophageal Reflux Drugs Value Chain

Figure 66. Gastroesophageal Reflux Drugs Production Process

Figure 67. Channels of Distribution (Direct Vs Distribution)

Figure 68. Distributors Profiles

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions